Human papillomavirus vaccination in adults: impact, opportunities and challenges - a meeting report.

ABSTRACT: For more than a decade human papillomavirus (HPV) vaccine have been implemented in most high-income countries, and more recently also in several low- and middle-income countries. The vaccines are safe and their impact and effectiveness in preventing HPV vaccine type infection and associated diseases has been thoroughly established. Currently, the primary recommended cohorts for immunisation are adolescents, 9-15 years of age but HPV is an ubiquitous infection that is mainly (but not exclusively) sexually transmitted. Sexually active adults remain susceptible to infection and continued transmission of the virus, representing a reservoir of infection in the population. A recent meeting, conducted by the HPV Prevention and Control Board (HPV-PCB), reviewed the current status of HPV vaccinatio

SUBMITTER: Waheed DE 

PROVIDER: S-EPMC8359761 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature